No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters
- 1 October 1997
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 76 (8) , 992-1000
- https://doi.org/10.1038/bjc.1997.498
Abstract
There is evidence that predisposition to cancer has a genetic component. Genetic models have suggested that there is at least one highly penetrant gene predisposing to this disease. The oncogene MXI1 on chromosome band 10q24-25 is mutated in a proportion of prostate tumours and loss of heterozygosity occurs at this site, suggesting the location of a tumour suppressor in this region. To investigate the possibility that MXI1 may be involved in inherited susceptibility to prostate cancer, we have sequenced the HLH and ZIP regions of the gene in 38 families with either three cases of prostate cancer or two affected siblings both diagnosed below the age of 67 years. These are the areas within which mutations have been described in some sporadic prostate cancers. No mutations were found in these two important coding regions and we therefore conclude that MXI1 does not make a major contribution to prostate cancer susceptibility.Keywords
This publication has 16 references indexed in Scilit:
- Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide SearchScience, 1996
- Mutation of the MXI1 gene in prostate cancerNature Genetics, 1995
- Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer ProbandsJNCI Journal of the National Cancer Institute, 1994
- Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2ANature, 1993
- Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sitesCell, 1993
- Family history and the risk of prostate cancerThe Prostate, 1990
- A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteinsCell, 1989
- A simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Research, 1988
- Enhanced expression of the c‐myc protooncogene in high‐grade human prostate cancersThe Prostate, 1987
- Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.Proceedings of the National Academy of Sciences, 1977